Co-Authors
This is a "connection" page, showing publications co-authored by Adalbert Krawczyk and Ulf Dittmer.
Connection Strength
2.095
-
Convalescent plasma treatment of critically ill intensive care COVID-19 patients. Transfusion. 2021 05; 61(5):1394-1403.
Score: 0.235
-
Glycyrrhizin Effectively Inhibits SARS-CoV-2 Replication by Inhibiting the Viral Main Protease. Viruses. 2021 04 02; 13(4).
Score: 0.234
-
Disinfection of SARS-CoV-2 Contaminated Surfaces of Personal Items with UVC-LED Disinfection Boxes. Viruses. 2021 03 31; 13(4).
Score: 0.234
-
Susceptibility of SARS-CoV-2 to UV irradiation. Am J Infect Control. 2020 10; 48(10):1273-1275.
Score: 0.224
-
Induction of herpes simplex virus type 1 cell-to-cell spread inhibiting antibodies by a calcium phosphate nanoparticle-based vaccine. Nanomedicine. 2019 02; 16:138-148.
Score: 0.200
-
Corrigendum to "Antibody-based immunotherapy of acyclovir resistant ocular herpes simplex virus infection" [Virology 512 (2017) 194-200]. Virology. 2019 01 02; 526:231-232.
Score: 0.197
-
A Therapeutic Antiviral Antibody Inhibits the Anterograde Directed Neuron-to-Cell Spread of Herpes Simplex Virus and Protects against Ocular Disease. Front Microbiol. 2017; 8:2115.
Score: 0.185
-
Antibody-based immunotherapy of aciclovir resistant ocular herpes simplex virus infections. Virology. 2017 12; 512:194-200.
Score: 0.184
-
SARS-CoV-2 Seroprevalence in Healthcare Workers in Germany: A Follow-Up Study. Int J Environ Res Public Health. 2021 04 25; 18(9).
Score: 0.059
-
SARS-CoV-2 infection induces sustained humoral immune responses in convalescent patients following symptomatic COVID-19. Nat Commun. 2021 03 22; 12(1):1813.
Score: 0.058
-
SARS-CoV-2-specific humoral and cellular immunity in two renal transplants and two hemodialysis patients treated with convalescent plasma. J Med Virol. 2021 05; 93(5):3047-3054.
Score: 0.058
-
Pasteurization Inactivates SARS-CoV-2-Spiked Breast Milk. Pediatrics. 2021 01; 147(1).
Score: 0.057
-
Cellular Immunity in COVID-19 Convalescents with PCR-Confirmed Infection but with Undetectable SARS-CoV-2-Specific IgG. Emerg Infect Dis. 2021 01; 27(1).
Score: 0.057
-
A Novel In-Cell ELISA Assay Allows Rapid and Automated Quantification of SARS-CoV-2 to Analyze Neutralizing Antibodies and Antiviral Compounds. Front Immunol. 2020; 11:573526.
Score: 0.057
-
SARS-CoV-2-specific antibody detection in healthcare workers in Germany with direct contact to COVID-19 patients. J Clin Virol. 2020 07; 128:104437.
Score: 0.055